Developer of eye-tracking metrics and devices designed to give medical professionals objective metrics for visual attention. The company's eye-tracking metrics and devices are fully-integrated, head-mounted eye-tracking device for rapid and reliable assessment of attention focus and it uses virtual reality to assess abnormal eye movement, enabling doctors to monitor and optimize brain health of patients.
Generating Revenue
Privately Held (backing)
Venture Capital-Backed
The company raised $7.43 million of Series A1 venture funding in a deal led by Quadrant on January 18, 2018. Other undisclosed investors also participated in the round. The funds will be used to further develop applications related to EYE-SYNC technology.
Add a review